It is unclear whether these findings regarding mucin-1 can be generalized to other populations and clinical scenarios, particularly to serve as an early prognostic alert for patients with IPF receiving different antifibrotic agents. The gene discussed is MUC1; the disease is idiopathic pulmonary fibrosis.